Adastra Holdings Ltd., a Canadian cannabis concentrates producer, reported a third consecutive year of record revenue for 2023, with a 108% increase to $37.7 million. However, the company also experienced higher losses, with a net loss of CA$3.54 million, up 17% from the previous year. The growth was attributed to the success of its in-house brand, Endgame Extracts. Despite the increased losses, Adastra achieved a record gross profit and cash provided by operating activities. The company anticipates continued momentum into 2024, including a record single purchase order of $1 million in March 2024, and plans to focus on cost-saving measures to ensure profitability.